Roberts, Carl A ORCID: 0000-0003-4275-601X and Halford, Jason CG ORCID: 0000-0003-1629-3189
(2018)
How does lorcaserin facilitate weight loss and who will benefit?
NATURE REVIEWS ENDOCRINOLOGY, 14 (12).
pp. 692-693.
Text
NV_Roberts_NREND-18-281_author accepted for elements.docx - Author Accepted Manuscript Download (22kB) |
Abstract
Pharmacotherapy for obesity, as an adjunct to targeted behavioural modifications, can facilitate weight loss. Previous serotonergic candidates have been withdrawn owing to undesirable cardiovascular effects. A new study in a large sample of high-risk patients shows lorcaserin treatment leads to no greater increase in cardiovascular problems than placebo — what does this result mean for personalized pharmacotherapy for obesity?
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Humans, Obesity, Weight Loss, Benzazepines, Overweight |
Depositing User: | Symplectic Admin |
Date Deposited: | 03 Jun 2019 13:33 |
Last Modified: | 19 Jan 2023 00:42 |
DOI: | 10.1038/s41574-018-0109-y |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3043674 |